Literature DB >> 19401491

Retinoid induction of alveolar regeneration: from mice to man?

M Hind1, A Gilthorpe, S Stinchcombe, M Maden.   

Abstract

The use of retinoids to induce human lung regeneration is under investigation in a number of studies in patients with chronic obstructive pulmonary disease (COPD). Retinoic acid (RA) has complex pleiotropic functions during vertebrate patterning and development and can induce regeneration in a number of different organ systems. Studies of retinoid signalling during lung development might provide a molecular basis to explain pharmacological induction of alveolar regeneration in adult models of lung disease. In this review the role of endogenous RA signalling during alveologenesis is explored and data suggesting that a number of exogenous retinoids can induce regeneration in the adult lung are discussed. Current controversies in this area are highlighted and a hypothesis of lung regeneration is put forward. Understanding the cellular and molecular mechanisms of induction of regeneration will be central for effective translation into patients with lung disease and may reveal novel insights into the pathogenesis of alveolar disease and senescence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401491     DOI: 10.1136/thx.2008.105437

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  Retinoic acid regulates avian lung branching through a molecular network.

Authors:  Hugo Fernandes-Silva; Patrícia Vaz-Cunha; Violina Baranauskaite Barbosa; Carla Silva-Gonçalves; Jorge Correia-Pinto; Rute Silva Moura
Journal:  Cell Mol Life Sci       Date:  2017-07-22       Impact factor: 9.261

2.  Synthetic Retinoid AM80 Ameliorates Lung and Arthritic Autoimmune Responses by Inhibiting T Follicular Helper and Th17 Cell Responses.

Authors:  Debdut Naskar; Fei Teng; Krysta M Felix; C Pierce Bradley; Hsin-Jung Joyce Wu
Journal:  J Immunol       Date:  2017-01-27       Impact factor: 5.422

3.  G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.

Authors:  Junya Fujimoto; Humam Kadara; Melinda M Garcia; Mohamed Kabbout; Carmen Behrens; Diane D Liu; J Jack Lee; Luisa M Solis; Edward S Kim; Neda Kalhor; Cesar Moran; Amir Sharafkhaneh; Reuben Lotan; Ignacio I Wistuba
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

Review 4.  Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease.

Authors:  Wei Shi; Felicia Chen; Wellington V Cardoso
Journal:  Proc Am Thorac Soc       Date:  2009-12-01

Review 5.  Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

Authors:  Iván P Uray; Ethan Dmitrovsky; Powel H Brown
Journal:  Semin Oncol       Date:  2015-09-25       Impact factor: 4.929

Review 6.  The roles of endogenous retinoid signaling in organ and appendage regeneration.

Authors:  Nicola Blum; Gerrit Begemann
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

Review 7.  The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases.

Authors:  Leah Cushing; Zhihua Jiang; Pingping Kuang; Jining Lü
Journal:  Am J Respir Cell Mol Biol       Date:  2015-04       Impact factor: 6.914

Review 8.  New anti-inflammatory targets for chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

Review 9.  Vitamin A in reproduction and development.

Authors:  Margaret Clagett-Dame; Danielle Knutson
Journal:  Nutrients       Date:  2011-03-29       Impact factor: 5.717

10.  Association of Forced Vital Capacity with the Developmental Gene NCOR2.

Authors:  Cosetta Minelli; Charlotte H Dean; Matthew Hind; Alexessander Couto Alves; André F S Amaral; Valerie Siroux; Ville Huikari; María Soler Artigas; David M Evans; Daan W Loth; Yohan Bossé; Dirkje S Postma; Don Sin; John Thompson; Florence Demenais; John Henderson; Emmanuelle Bouzigon; Deborah Jarvis; Marjo-Riitta Järvelin; Peter Burney
Journal:  PLoS One       Date:  2016-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.